SS

Satish Shivaji Bandal

Active Director Designated Partner DIN 11680556
DIN 11680556 First appointment Apr 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Satish Shivaji Bandal

Data last updated:

Satish Shivaji Bandal is a Designated Partner at Shri Gurudatta Hospital Jejuri Llp (since 2026).

DIN 11680556
Primary Designation Designated Partner
First Appointment 22 Apr 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner22 Apr 20262026Active

Board colleagues of Satish Shivaji Bandal

NameDINCompanyDesignation
Anand Govind Salunkhe11680554Shri Gurudatta Hospital Jejuri LlpDesignated Partner
Uttam Bandu Shilimkar11680555Shri Gurudatta Hospital Jejuri LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Shri Gurudatta Hospital Jejuri Llp
Premium access

Shareholding and investment profile for Satish Shivaji Bandal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Satish Shivaji Bandal

Satish Shivaji Bandal currently holds 1 directorship: Shri Gurudatta Hospital Jejuri Llp (Designated Partner, since 22 Apr 2026).

Satish Shivaji Bandal was first appointed on 22 Apr 2026 as Designated Partner at Shri Gurudatta Hospital Jejuri Llp.

The current boards of Satish Shivaji Bandal's companies include Anand Govind Salunkhe (Shri Gurudatta Hospital Jejuri Llp), Uttam Bandu Shilimkar (Shri Gurudatta Hospital Jejuri Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available